Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.75 - $3.99 $60,225 - $87,381
-21,900 Closed
0 $0
Q2 2024

Aug 14, 2024

BUY
$3.02 - $4.7 $28,388 - $44,180
9,400 Added 75.2%
21,900 $72,000
Q1 2024

May 13, 2024

SELL
$4.53 - $8.41 $122,776 - $227,936
-27,103 Reduced 68.44%
12,500 $58,000
Q4 2023

Oct 21, 2024

BUY
$3.22 - $11.79 $57,003 - $208,718
17,703 Added 80.84%
39,603 $289,000
Q4 2023

Feb 07, 2024

BUY
$3.22 - $11.79 $127,521 - $466,919
39,603 New
39,603 $289,000
Q4 2022

Feb 13, 2023

BUY
$12.5 - $18.13 $122,500 - $177,674
9,800 Added 53.85%
28,000 $411,000
Q3 2022

Nov 07, 2022

BUY
$11.57 - $15.59 $210,574 - $283,738
18,200 New
18,200 $221,000
Q4 2021

Feb 10, 2022

SELL
$19.66 - $28.11 $218,226 - $312,021
-11,100 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$25.71 - $35.24 $285,381 - $391,164
11,100 New
11,100 $291,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.